PRIVIA HEALTH GROUP INC (PRVA) Stock Earnings & Estimates
USA - NASDAQ:PRVA - US74276R1023 - Common Stock
25.53 USD
0 (0%)
25.53 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.357B 40.42% | 1.658B 22.19% | 1.736B 4.74% | 3.419B 96.90% | 3.454B 1.02% | 3.6B 4.23% | 2.924B -18.78% | 3.311B 13.24% | 3.754B 13.38% | 3.101B -17.39% | |
| EBITDA YoY % growth | -14.53M 93.24% | 27.182M 287.08% | 24.25M -10.79% | 114.99M 374.19% | 135.92M 18.20% | 161.07M 18.50% | 190.03M 17.98% | 220.52M 16.04% | 253.37M 14.90% | 288.66M 13.93% | |
| EBIT YoY % growth | -19.1M 91.21% | 20.649M 208.11% | 16.982M -17.76% | 24.453M 43.99% | 48.186M 97.06% | 83.506M 73.30% | 106.79M 27.88% | 135.86M 27.22% | 167.18M 23.05% | 200.94M 20.19% | |
| Operating Margin | -1.41% | 1.25% | 0.98% | 0.72% | 1.40% | 2.32% | 3.65% | 4.10% | 4.45% | 6.48% | |
| EPS YoY % growth | 0.13 107.14% | 0.19 46.15% | 0.11 -42.11% | 0.17 51.21% | 0.32 93.60% | 0.44 37.56% | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.05 83.09% | 0.06 113.42% | 0.07 125.32% | 0.08 300.15% | 0.09 63.05% | 0.09 46.41% | 0.12 73.53% | 0.11 33.83% | 0.11 19.59% | 0.11 19.70% |
| Revenue Q2Q % growth | 760.94M 2.84% | 766.35M -3.30% | 869.04M 8.82% | 897.71M 4.03% | 875.01M 14.99% | 887.6M 15.82% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 28.346M 151.99% | 29.903M 138.92% | 32.448M 355.79% | 33.264M 325.37% | 34.421M 21.43% | 35.27M 17.95% | 39.95M 23.12% | 39.438M 18.56% | 39.742M 15.46% | 40.6M 15.11% |
| EBIT Q2Q % growth | 7.774M 33.73% | 9.416M 79.42% | 10.202M 95.52% | 11.305M 238.88% | 13.586M 74.76% | 15.565M 65.30% | 18.197M 78.37% | 16.295M 44.14% | 17.075M 25.68% | 17.376M 11.64% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.02 -33.33% | 0.05 | -0.03 | -60.96% |
| Q1 2025 Q2Q % growth | 0.03 50.00% | 0.05 | -0.02 | -37.83% |
| Q4 2024 Q2Q % growth | 0.03 50.00% | 0.05 | -0.02 | -40.79% |
| Q3 2024 Q2Q % growth | 0.03 -40.00% | 0.05 | -0.02 | -38.73% |
| Q2 2024 Q2Q % growth | 0.03 -50.00% | 0.05 | -0.02 | -36.27% |
| Q1 2024 Q2Q % growth | 0.02 -66.67% | 0.05 | -0.03 | -58.84% |
| Q4 2023 Q2Q % growth | 0.02 -85.71% | 0.04 | -0.02 | -53.66% |
| Q3 2023 Q2Q % growth | 0.05 400.00% | 0.05 | 0.00 | -1.96% |
| Q2 2023 Q2Q % growth | 0.06 -57.14% | 0.06 | 0.00 | 5.32% |
| Q1 2023 Q2Q % growth | 0.06 137.50% | 0.02 | 0.04 | 222.32% |
| Q4 2022 Q2Q % growth | 0.14 227.27% | -0.03 | 0.17 | 596.58% |
| Q3 2022 Q2Q % growth | 0.01 111.11% | 0.00 | 0.01 | 105.10% |
| Q2 2022 Q2Q % growth | 0.14 108.33% | -0.03 | 0.17 | 625.68% |
| Q1 2022 Q2Q % growth | -0.16 -366.67% | -0.04 | -0.12 | -331.77% |
| Q4 2021 Q2Q % growth | -0.11 | -0.14 | 0.03 | 19.35% |
| Q3 2021 Q2Q % growth | -0.09 | -0.11 | 0.02 | 18.52% |
| Q2 2021 Q2Q % growth | -1.68 | -1.72 | 0.04 | 2.54% |
| Q1 2021 Q2Q % growth | 0.06 | 0.04 | 0.02 | 34.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 862.9M 18.53% | 816.11M | 46.79M | 5.73% |
| Q1 2025 Q2Q % growth | 798.6M 12.84% | 792.62M | 5.98M | 0.75% |
| Q4 2024 Q2Q % growth | 792.5M 4.74% | 734.37M | 58.13M | 7.92% |
| Q3 2024 Q2Q % growth | 739.9M 2.27% | 729.08M | 10.82M | 1.48% |
| Q2 2024 Q2Q % growth | 728M 4.00% | 720.57M | 7.43M | 1.03% |
| Q1 2024 Q2Q % growth | 707.7M 7.41% | 667.44M | 40.26M | 6.03% |
| Q4 2023 Q2Q % growth | 756.6M 107.63% | 739.91M | 16.69M | 2.26% |
| Q3 2023 Q2Q % growth | 723.5M 110.99% | 716.51M | 6.99M | 0.98% |
| Q2 2023 Q2Q % growth | 700M 108.64% | 699.7M | 300K | 0.04% |
| Q1 2023 Q2Q % growth | 658.9M 109.97% | 666.03M | -7.13M | -1.07% |
| Q4 2022 Q2Q % growth | 364.4M 32.36% | 598.88M | -234.48M | -39.15% |
| Q3 2022 Q2Q % growth | 342.9M 36.34% | 541.28M | -198.38M | -36.65% |
| Q2 2022 Q2Q % growth | 335.5M 48.58% | 533.59M | -198.09M | -37.12% |
| Q1 2022 Q2Q % growth | 313.8M 46.91% | 521.87M | -208.07M | -39.87% |
| Q4 2021 Q2Q % growth | 275.3M 28.83% | 426.82M | -151.52M | -35.50% |
| Q3 2021 Q2Q % growth | 251.5M 21.38% | 237.27M | 14.23M | 6.00% |
| Q2 2021 Q2Q % growth | 225.8M 23.19% | 219.32M | 6.48M | 2.95% |
| Q1 2021 Q2Q % growth | 213.6M 0.33% | 201.27M | 12.33M | 6.13% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.32% | -13.58% | 0.79% | -20.73% |
| Revenue | -7.7% | -8.03% | -0.32% | 3.39% |